Evaluation Of Combination Nutritional Supplement Therapies In The Prevention Of Alzheimers Disease In
Funder
National Health and Medical Research Council
Funding Amount
$484,675.00
Summary
Age-related diseases are becoming a major concern as the world’s population grows older due to advances in medical technology, health and nutrition. Dementia accounts for a large proportion of agerelated diseases and is characterised clinically by deterioration in memory and cognitive processing. AD is the most common form of cerebral degeneration leading to dementia. Currently over 200,000 Australians suffer from dementia, with AD, accounting for 50-70% of all cases. At this rate, the number of ....Age-related diseases are becoming a major concern as the world’s population grows older due to advances in medical technology, health and nutrition. Dementia accounts for a large proportion of agerelated diseases and is characterised clinically by deterioration in memory and cognitive processing. AD is the most common form of cerebral degeneration leading to dementia. Currently over 200,000 Australians suffer from dementia, with AD, accounting for 50-70% of all cases. At this rate, the number of people in Australia with dementia will increase to 730,000 by the year 2050. Thus, there is an urgent need for effective preventative treatments for this devastating disease, as dementia will soon be the major cause of disability in Australia. As a result, the social and economic consequences of this disease present a significant challenge to society, and it is imperative that strategies to prevent or delay the onset of AD are developed. If complimentary and alternative medicine (CAM) therapies could be developed to prevent or delay the onset for Alzheimer’s disease, the impact on disease burden could be substantial. However, these CAM therapies need to be critically evaluated for their mechanisms, efficacy and safety before human clinical trial are undertaken. The proposed research plan will evaluate the efficacy of the nutritional supplements of polyphenols (EGCG from green tea and curcumin), omega-3 essential fatty acids (docosahexaenoic acid) and lipoic acid to determine whether these treatments in combination offer preventative therapies for AD. The findings from the current study will provide important information concerning the effects of combination supplements in preventing cognitive deficits and AD pathology in a transgenic mouse model. Combination treatments may reduce cognitive deficits (memory and learning), oxidative stress and AD pathology, thereby providing an important insight into possible CAM preventative treatment strategies for AD. The development of effective preventative strategies for the treatment of AD is critical if we are to reduce the number of people that are expected to develop AD over the next 50 years, due to the rapidly aging population. The outcomes of this research may provide disease modifying therapies for the prevention of AD.Read moreRead less
Regulation And Activity Of Fatty Acid Delta-6 Desaturase (D6D)
Funder
National Health and Medical Research Council
Funding Amount
$527,683.00
Summary
Fish and fish oils contain fats known as omega-3 fats. These have health benefits in adult conditions such as rheumatoid arthritis and heart disease, and they are necessary for proper brain and eye development in infants. However, much of the population does not like to eat fish and also, world fish stocks are under stress. Thus, a sustainable alternative source of omega-3 fats needs to be explored. Some vegetable oils such as canola, echium, and flaxseed oils have omega-3 fats. However, these a ....Fish and fish oils contain fats known as omega-3 fats. These have health benefits in adult conditions such as rheumatoid arthritis and heart disease, and they are necessary for proper brain and eye development in infants. However, much of the population does not like to eat fish and also, world fish stocks are under stress. Thus, a sustainable alternative source of omega-3 fats needs to be explored. Some vegetable oils such as canola, echium, and flaxseed oils have omega-3 fats. However, these are not the same as the omega-3s in fish oil. In general, vegetable omega-3s are known as short-chain omega-3s whereas those in fish are long-chain. When the vegetable oil omega-3s are consumed in the diet, the body must convert them to the fish-type, or long-chain, omega-3s in order to gain the health benefits. Currently, human metabolism is poor at doing this conversion. Our studies suggest that the amounts and blends of fats in most diets are well below optimal for conversion to long-chain omega-3s in the body. In particular, our studies show that there may be no point in simply adding more vegetable omega-3 fats to the diet. This project will examine the enzymes that convert the short-chain to the long-chain omega-3 fats. In particular, it will examine how the dietary fats interact with each other in detrimental ways to suppress activity of the conversion enzymes necessary for long-chain omega-3 formation. Evidence for the health benefits of fish-based omega-3 fats is very strong and it is an approach to health that most people can undertake on their own. Our lack of knowledge of the best way to use plant-based omega-3 fats is a large impediment for a more sustainable and broader based use of omega-3 fats. The results from this study will begin to fill in this knowledge gap. The results will be useful across a range of activities that are determinants of the kinds of fat that we eat. These include oil seed breeding, food manufacture, and dietetics.Read moreRead less
Fatty Acid Biosynthesis In The Malaria Chloroplast As A Drug Target
Funder
National Health and Medical Research Council
Funding Amount
$131,035.00
Summary
Malarial parasites contain a chloroplast similar to that of plants. We recently found genetic evidence suggesting the malaria chloroplast makes fats in the same way as plant chloroplasts. Additionally, we have found that drugs and herbicides that block plant chloroplast fat production stop growth of malaria cultures. Parasitologists had assumed that malaria was unable to make fats and would scavenge them from its human host so we have probably discovered a new metabolic pathway in these parasite ....Malarial parasites contain a chloroplast similar to that of plants. We recently found genetic evidence suggesting the malaria chloroplast makes fats in the same way as plant chloroplasts. Additionally, we have found that drugs and herbicides that block plant chloroplast fat production stop growth of malaria cultures. Parasitologists had assumed that malaria was unable to make fats and would scavenge them from its human host so we have probably discovered a new metabolic pathway in these parasites. We now propose to prove that the drugs work by blocking essential, chloroplast-based fat production in parasites. This could lead to novel treatment of malaria and related parasites.Read moreRead less
Inhibition Of Glucose-stimulated Insulin Secretion By Protein Kinase C Epsilon
Funder
National Health and Medical Research Council
Funding Amount
$555,693.00
Summary
Type 2 diabetes is a chronic disease which occurs when the pancreas is unable to produce enough insulin for the body to cope with rising blood glucose levels after a meal, and is strongly linked to obesity. We have discovered that fat oversupply activates an enzyme in the pancreas causing defects in insulin release due to glucose. Inhibiting this enzyme helps overcome diabetes, through poorly defined mechanisms that we aim to clarify here. Our work could lead to new therapies for diabetes.